GLP-1 Market Size, Share, and Trends 2026 to 2035

Chapter 1. Introduction

1.1. Research Objective

1.2. Scope of the Study

1.3. Definition

Chapter 2. Research Methodology  

2.1. Research Approach

2.2. Data Sources

2.3. Assumptions & Limitations

Chapter 3. Executive Summary

3.1. Market Snapshot

Chapter 4. Market Variables and Scope 

4.1. Introduction

4.2. Market Classification and Scope

4.3. Industry Value Chain Analysis

4.3.1. Raw Material Procurement Analysis 

4.3.2. Sales and Distribution Channel Analysis

4.3.3. Downstream Buyer Analysis

Chapter 5. Market Dynamics Analysis and Trends

5.1. Market Dynamics

5.1.1. Market Drivers

5.1.2. Market Restraints

5.1.3. Market Opportunities

5.2. Porter’s Five Forces Analysis

5.2.1. Bargaining power of suppliers

5.2.2. Bargaining power of buyers

5.2.3. Threat of substitute

5.2.4. Threat of new entrants

5.2.5. Degree of competition

Chapter 6. Competitive Landscape

6.1.1. Company Market Share/Positioning Analysis

6.1.2. Key Strategies Adopted by Players

6.1.3. Vendor Landscape

6.1.3.1. List of Suppliers

6.1.3.2. List of Buyers

Chapter 7. Global GLP-1 Market, By Product Type

7.1. GLP-1 Market Revenue and Volume, by Product Type

7.1.1. GLP-1 Receptor Agonists

7.1.1.1. Market Revenue and Volume Forecast

7.1.2. Oral GLP-1 Therapies

7.1.2.1. Market Revenue and Volume Forecast

7.1.3. Injectable GLP-1 Therapies

7.1.3.1. Market Revenue and Volume Forecast

Chapter 8. Global GLP-1 Market, By Route of Administration

8.1. GLP-1 Market Revenue and Volume, by Route of Administration

8.1.1. Injectable

8.1.1.1. Market Revenue and Volume Forecast

8.1.2. Once Daily

8.1.2.1. Market Revenue and Volume Forecast

8.1.3. Once Weekly

8.1.3.1. Market Revenue and Volume Forecast

8.1.4. Oral

8.1.4.1. Market Revenue and Volume Forecast

Chapter 9. Global GLP-1 Market, By Indication

9.1. GLP-1 Market Revenue and Volume, by Indication

9.1.1. Type 2 Diabetes Mellitus

9.1.1.1. Market Revenue and Volume Forecast

9.1.2. Obesity & Weight Management

9.1.2.1. Market Revenue and Volume Forecast

9.1.3. Cardiovascular Risk Reduction

9.1.3.1. Market Revenue and Volume Forecast

9.1.4. Non-Alcoholic Steatohepatitis (NASH)/MASH

9.1.4.1. Market Revenue and Volume Forecast

9.1.5. Chronic Kidney Disease (CKD)

9.1.5.1. Market Revenue and Volume Forecast

Chapter 10. Global GLP-1 Market, By Drug Class

10.1. GLP-1 Market Revenue and Volume, by Drug Class

10.1.1. Short-acting GLP-1 Agonists

10.1.1.1. Market Revenue and Volume Forecast

10.1.2. Long-acting GLP-1 Agonists

10.1.2.1. Market Revenue and Volume Forecast

10.1.3. Dual Incretin Agonists

10.1.3.1. Market Revenue and Volume Forecast

10.1.4. Triple Agonists (Pipeline)

10.1.4.1. Market Revenue and Volume Forecast

Chapter 11. Global GLP-1 Market, By Distribution Channel

11.1. GLP-1 Market Revenue and Volume, by Distribution Channel

11.1.1. Hospital Pharmacies

11.1.1.1. Market Revenue and Volume Forecast

11.1.2. Retail Pharmacies

11.1.2.1. Market Revenue and Volume Forecast

11.1.3. Online Pharmacies

11.1.3.1. Market Revenue and Volume Forecast

Chapter 12. Global GLP-1 Market, By Online Pharmacies

12.1. GLP-1 Market Revenue and Volume, by Online Pharmacies

12.1.1. Hospitals

12.1.1.1. Market Revenue and Volume Forecast

12.1.2. Specialty Clinics

12.1.2.1. Market Revenue and Volume Forecast

12.1.3. Homecare Settings

12.1.3.1. Market Revenue and Volume Forecast

12.1.4. Ambulatory Care Centers

12.1.4.1. Market Revenue and Volume Forecast

Chapter 13. Global GLP-1 Market, By Age Group

13.1. GLP-1 Market Revenue and Volume, by Age Group

13.1.1. Adults

13.1.1.1. Market Revenue and Volume Forecast

13.1.2. Geriatric

13.1.2.1. Market Revenue and Volume Forecast

13.1.3. Pediatric

13.1.3.1. Market Revenue and Volume Forecast

Chapter 14. Global GLP-1 Market, By Pediatric

14.1. GLP-1 Market Revenue and Volume, by Pediatric

14.1.1. Public Insurance

14.1.1.1. Market Revenue and Volume Forecast

14.1.2. Private Insurance

14.1.2.1. Market Revenue and Volume Forecast

14.1.3. Out-of-Pocket

14.1.3.1. Market Revenue and Volume Forecast

Chapter 15. Global GLP-1 Market, Regional Estimates and Trend Forecast

15.1. North America

15.1.1. Market Revenue and Volume Forecast, by Product Type

15.1.2. Market Revenue and Volume Forecast, by Route of Administration

15.1.3. Market Revenue and Volume Forecast, by Indication

15.1.4. Market Revenue and Volume Forecast, by Drug Class

15.1.5. Market Revenue and Volume Forecast, by Distribution Channel

15.1.6. Market Revenue and Volume Forecast, by Online Pharmacies

15.1.7. Market Revenue and Volume Forecast, by Age Group

15.1.8. Market Revenue and Volume Forecast, by Pediatric

15.1.9. U.S.

15.1.9.1. Market Revenue and Volume Forecast, by Product Type

15.1.9.2. Market Revenue and Volume Forecast, by Route of Administration

15.1.9.3. Market Revenue and Volume Forecast, by Indication

15.1.9.4. Market Revenue and Volume Forecast, by Drug Class

15.1.9.5.  Market Revenue and Volume Forecast, by Distribution Channel

15.1.9.6. Market Revenue and Volume Forecast, by Online Pharmacies

15.1.9.7. Market Revenue and Volume Forecast, by Age Group

15.1.9.8. Market Revenue and Volume Forecast, by Pediatric

15.1.10. Rest of North America

15.1.10.1. Market Revenue and Volume Forecast, by Product Type

15.1.10.2. Market Revenue and Volume Forecast, by Route of Administration

15.1.10.3. Market Revenue and Volume Forecast, by Indication

15.1.10.4. Market Revenue and Volume Forecast, by Drug Class

15.1.10.5. Market Revenue and Volume Forecast, by Distribution Channel

15.1.10.6. Market Revenue and Volume Forecast, by Online Pharmacies

15.1.10.7. Market Revenue and Volume Forecast, by Age Group

15.1.10.8. Market Revenue and Volume Forecast, by Pediatric

15.2. Europe

15.2.1. Market Revenue and Volume Forecast, by Product Type

15.2.2. Market Revenue and Volume Forecast, by Route of Administration

15.2.3. Market Revenue and Volume Forecast, by Indication

15.2.4. Market Revenue and Volume Forecast, by Drug Class

15.2.5. Market Revenue and Volume Forecast, by Distribution Channel

15.2.6. Market Revenue and Volume Forecast, by Online Pharmacies

15.2.7. Market Revenue and Volume Forecast, by Age Group

15.2.8. Market Revenue and Volume Forecast, by Pediatric

15.2.9. UK

15.2.9.1. Market Revenue and Volume Forecast, by Product Type

15.2.9.2. Market Revenue and Volume Forecast, by Route of Administration

15.2.9.3. Market Revenue and Volume Forecast, by Indication

15.2.9.4. Market Revenue and Volume Forecast, by Drug Class

15.2.9.5. Market Revenue and Volume Forecast, by Distribution Channel

15.2.9.6. Market Revenue and Volume Forecast, by Online Pharmacies

15.2.9.7. Market Revenue and Volume Forecast, by Age Group

15.2.9.8. Market Revenue and Volume Forecast, by Pediatric

15.2.10. Germany

15.2.10.1. Market Revenue and Volume Forecast, by Product Type

15.2.10.2. Market Revenue and Volume Forecast, by Route of Administration

15.2.10.3. Market Revenue and Volume Forecast, by Indication

15.2.10.4. Market Revenue and Volume Forecast, by Drug Class

15.2.10.5. Market Revenue and Volume Forecast, by Distribution Channel 

15.2.10.6. Market Revenue and Volume Forecast, by Online Pharmacies

15.2.10.7. Market Revenue and Volume Forecast, by Age Group

15.2.10.8. Market Revenue and Volume Forecast, by Pediatric

15.2.11.  France

15.2.11.1. Market Revenue and Volume Forecast, by Product Type

15.2.11.2. Market Revenue and Volume Forecast, by Route of Administration

15.2.11.3. Market Revenue and Volume Forecast, by Indication

15.2.11.4. Market Revenue and Volume Forecast, by Drug Class

15.2.11.5. Market Revenue and Volume Forecast, by Distribution Channel 

15.2.11.6. Market Revenue and Volume Forecast, by Online Pharmacies

15.2.11.7. Market Revenue and Volume Forecast, by Pediatric

15.2.11.8. Market Revenue and Volume Forecast, by Age Group

15.2.12. Rest of Europe

15.2.12.1. Market Revenue and Volume Forecast, by Product Type

15.2.12.2. Market Revenue and Volume Forecast, by Route of Administration

15.2.12.3. Market Revenue and Volume Forecast, by Indication

15.2.12.4. Market Revenue and Volume Forecast, by Drug Class

15.2.12.5. Market Revenue and Volume Forecast, by Distribution Channel 

15.2.12.6. Market Revenue and Volume Forecast, by Online Pharmacies

15.2.12.7. Market Revenue and Volume Forecast, by Age Group

15.2.12.8. Market Revenue and Volume Forecast, by Pediatric

15.3. APAC

15.3.1. Market Revenue and Volume Forecast, by Product Type

15.3.2. Market Revenue and Volume Forecast, by Route of Administration

15.3.3. Market Revenue and Volume Forecast, by Indication

15.3.4. Market Revenue and Volume Forecast, by Drug Class

15.3.5. Market Revenue and Volume Forecast, by Distribution Channel

15.3.6. Market Revenue and Volume Forecast, by Online Pharmacies

15.3.7. Market Revenue and Volume Forecast, by Age Group

15.3.8. Market Revenue and Volume Forecast, by Pediatric

15.3.9. India

15.3.9.1. Market Revenue and Volume Forecast, by Product Type

15.3.9.2. Market Revenue and Volume Forecast, by Route of Administration

15.3.9.3. Market Revenue and Volume Forecast, by Indication

15.3.9.4. Market Revenue and Volume Forecast, by Drug Class

15.3.9.5. Market Revenue and Volume Forecast, by Distribution Channel

15.3.9.6. Market Revenue and Volume Forecast, by Online Pharmacies

15.3.9.7. Market Revenue and Volume Forecast, by Age Group

15.3.9.8. Market Revenue and Volume Forecast, by Pediatric

15.3.10. China

15.3.10.1. Market Revenue and Volume Forecast, by Product Type

15.3.10.2. Market Revenue and Volume Forecast, by Route of Administration

15.3.10.3. Market Revenue and Volume Forecast, by Indication

15.3.10.4. Market Revenue and Volume Forecast, by Drug Class

15.3.10.5. Market Revenue and Volume Forecast, by Distribution Channel 

15.3.10.6. Market Revenue and Volume Forecast, by Online Pharmacies

15.3.10.7. Market Revenue and Volume Forecast, by Age Group

15.3.10.8. Market Revenue and Volume Forecast, by Pediatric

15.3.11. Japan

15.3.11.1. Market Revenue and Volume Forecast, by Product Type

15.3.11.2. Market Revenue and Volume Forecast, by Route of Administration

15.3.11.3. Market Revenue and Volume Forecast, by Indication

15.3.11.4. Market Revenue and Volume Forecast, by Drug Class

15.3.11.5. Market Revenue and Volume Forecast, by Distribution Channel 

15.3.11.6. Market Revenue and Volume Forecast, by Online Pharmacies

15.3.11.7. Market Revenue and Volume Forecast, by Age Group

15.3.11.8. Market Revenue and Volume Forecast, by Pediatric

15.3.12. Rest of APAC

15.3.12.1. Market Revenue and Volume Forecast, by Product Type

15.3.12.2. Market Revenue and Volume Forecast, by Route of Administration

15.3.12.3. Market Revenue and Volume Forecast, by Indication

15.3.12.4. Market Revenue and Volume Forecast, by Drug Class

15.3.12.5. Market Revenue and Volume Forecast, by Distribution Channel 

15.3.12.6. Market Revenue and Volume Forecast, by Online Pharmacies

15.3.12.7. Market Revenue and Volume Forecast, by Age Group

15.3.12.8. Market Revenue and Volume Forecast, by Pediatric

15.4. MEA

15.4.1. Market Revenue and Volume Forecast, by Product Type

15.4.2. Market Revenue and Volume Forecast, by Route of Administration

15.4.3. Market Revenue and Volume Forecast, by Indication

15.4.4. Market Revenue and Volume Forecast, by Drug Class

15.4.5. Market Revenue and Volume Forecast, by Distribution Channel

15.4.6. Market Revenue and Volume Forecast, by Online Pharmacies

15.4.7. Market Revenue and Volume Forecast, by Age Group

15.4.8. Market Revenue and Volume Forecast, by Pediatric

15.4.9. GCC

15.4.9.1. Market Revenue and Volume Forecast, by Product Type

15.4.9.2. Market Revenue and Volume Forecast, by Route of Administration

15.4.9.3. Market Revenue and Volume Forecast, by Indication

15.4.9.4. Market Revenue and Volume Forecast, by Drug Class

15.4.9.5. Market Revenue and Volume Forecast, by Distribution Channel

15.4.9.6. Market Revenue and Volume Forecast, by Online Pharmacies

15.4.9.7. Market Revenue and Volume Forecast, by Age Group

15.4.9.8. Market Revenue and Volume Forecast, by Pediatric

15.4.10. North Africa

15.4.10.1. Market Revenue and Volume Forecast, by Product Type

15.4.10.2. Market Revenue and Volume Forecast, by Route of Administration

15.4.10.3. Market Revenue and Volume Forecast, by Indication

15.4.10.4. Market Revenue and Volume Forecast, by Drug Class

15.4.10.5. Market Revenue and Volume Forecast, by Distribution Channel 

15.4.10.6. Market Revenue and Volume Forecast, by Online Pharmacies

15.4.10.7. Market Revenue and Volume Forecast, by Age Group

15.4.10.8. Market Revenue and Volume Forecast, by Pediatric

15.4.11. South Africa

15.4.11.1. Market Revenue and Volume Forecast, by Product Type

15.4.11.2. Market Revenue and Volume Forecast, by Route of Administration

15.4.11.3. Market Revenue and Volume Forecast, by Indication

15.4.11.4. Market Revenue and Volume Forecast, by Drug Class

15.4.11.5. Market Revenue and Volume Forecast, by Distribution Channel 

15.4.11.6. Market Revenue and Volume Forecast, by Online Pharmacies

15.4.11.7. Market Revenue and Volume Forecast, by Age Group

15.4.11.8. Market Revenue and Volume Forecast, by Pediatric

15.4.12. Rest of MEA

15.4.12.1. Market Revenue and Volume Forecast, by Product Type

15.4.12.2. Market Revenue and Volume Forecast, by Route of Administration

15.4.12.3. Market Revenue and Volume Forecast, by Indication

15.4.12.4. Market Revenue and Volume Forecast, by Drug Class

15.4.12.5. Market Revenue and Volume Forecast, by Distribution Channel 

15.4.12.6. Market Revenue and Volume Forecast, by Online Pharmacies

15.4.12.7. Market Revenue and Volume Forecast, by Age Group

15.4.12.8. Market Revenue and Volume Forecast, by Pediatric

15.5. Latin America

15.5.1. Market Revenue and Volume Forecast, by Product Type

15.5.2. Market Revenue and Volume Forecast, by Route of Administration

15.5.3. Market Revenue and Volume Forecast, by Indication

15.5.4. Market Revenue and Volume Forecast, by Drug Class

15.5.5. Market Revenue and Volume Forecast, by Distribution Channel 

15.5.6. Market Revenue and Volume Forecast, by Online Pharmacies

15.5.7. Market Revenue and Volume Forecast, by Age Group

15.5.8. Market Revenue and Volume Forecast, by Pediatric

15.5.9. Brazil

15.5.9.1. Market Revenue and Volume Forecast, by Product Type

15.5.9.2. Market Revenue and Volume Forecast, by Route of Administration

15.5.9.3. Market Revenue and Volume Forecast, by Indication

15.5.9.4. Market Revenue and Volume Forecast, by Drug Class

15.5.9.5. Market Revenue and Volume Forecast, by Distribution Channel

15.5.9.6. Market Revenue and Volume Forecast, by Online Pharmacies

15.5.9.7. Market Revenue and Volume Forecast, by Age Group

15.5.9.8. Market Revenue and Volume Forecast, by Pediatric

15.5.10.   Rest of LATAM

15.5.10.1. Market Revenue and Volume Forecast, by Product Type

15.5.10.2. Market Revenue and Volume Forecast, by Route of Administration

15.5.10.3. Market Revenue and Volume Forecast, by Indication

15.5.10.4. Market Revenue and Volume Forecast, by Drug Class

15.5.10.5. Market Revenue and Volume Forecast, by Distribution Channel 

15.5.10.6. Market Revenue and Volume Forecast, by Online Pharmacies

15.5.10.7. Market Revenue and Volume Forecast, by Age Group

15.5.10.8. Market Revenue and Volume Forecast, by Pediatric

Chapter 16. Company Profiles

16.1. Novo Nordisk

16.1.1. Company Overview

16.1.2. Product Offerings

16.1.3. Financial Performance

16.1.4. Recent Initiatives

16.2. Eli Lilly and Company

16.2.1. Company Overview

16.2.2. Product Offerings

16.2.3. Financial Performance

16.2.4. Recent Initiatives

16.3. Zealand Pharma

16.3.1. Company Overview

16.3.2. Product Offerings

16.3.3. Financial Performance

16.3.4. Recent Initiatives

16.4. Structure Therapeutics

16.4.1. Company Overview

16.4.2. Product Offerings

16.4.3. Financial Performance

16.4.4. Recent Initiatives

16.5. Amgen

16.5.1. Company Overview

16.5.2. Product Offerings

16.5.3. Financial Performance

16.5.4. Recent Initiatives

16.6. Viking Therapeutics

16.6.1. Company Overview

16.6.2. Product Offerings

16.6.3. Financial Performance

16.6.4. Recent Initiatives

16.7. Sanofi

16.7.1. Company Overview

16.7.2. Product Offerings

16.7.3. Financial Performance

16.7.4. Recent Initiatives

16.8. AstraZeneca

16.8.1. Company Overview

16.8.2. Product Offerings

16.8.3. Financial Performance

16.8.4. Recent Initiatives

16.9. Hansoh Pharmaceutical Group Co. Ltd.

16.9.1. Company Overview

16.9.2. Product Offerings

16.9.3. Financial Performance

16.9.4. Recent Initiatives

16.10. Abbott

16.10.1. Company Overview

16.10.2. Product Offerings

16.10.3. Financial Performance

16.10.4. Recent Initiatives

Chapter 17. Research Methodology

16.7. Primary Research

16.7. Secondary Research

16.7. Assumptions

Chapter 18. Appendix

18.1. About Us

18.2. Glossary of Terms